Last $0.0002 USD
Change Today 0.00 / 0.00%
Volume 0.0
CVSC On Other Exchanges
As of 4:30 PM 11/4/14 All times are local (Market data is delayed by at least 15 minutes).

cardiovascular sciences inc (CVSC) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/4/14 - $0.0002
52 Week Low
08/27/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

cardiovascular sciences inc (CVSC) Related Businessweek News

No Related Businessweek News Found

cardiovascular sciences inc (CVSC) Details

Cardiovascular Sciences Inc. manufactures medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic reperfusion injury, heart failure, and bypass surgery; Thromboresistant Coating that prevents blood clot formation on medical devices; a biocompatible Human Vascular Tissue Equivalent for artery replacement during heart surgeries; and patented Aortic Catheters. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences Inc. in May 2006. The company is based in Casselberry, Florida. Cardiovascular Sciences Inc. operates as a subsidiary of Advanced Content Services, Inc.

cardiovascular sciences inc (CVSC) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: --
Total Annual Compensation: --
Chief Financial Officer, Secretary, Treasurer...
Total Annual Compensation: --
Director of Operations
Total Annual Compensation: --
President of Weight Loss & Wellness
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

cardiovascular sciences inc (CVSC) Key Developments

Volcano Corporation Filed Suit in Federal District Court Against St. Jude Medical, Cardiovascular, Ablation Technologies Division, Inc., St. Jude Medical, Cardiology Division, Inc., St. Jude Medical, U.S. Division, St. Jude Medical S.C. Inc., and St. Jude Medical Systems AB

On April 16, 2013, Volcano Corporation filed suit in Federal District Court in Delaware against St. Jude Medical, Cardiovascular and Ablation Technologies Division, Inc., St. Jude Medical, Cardiology Division, Inc., St. Jude Medical, U.S. Division, St. Jude Medical S.C. Inc., and St. Jude Medical Systems AB, (collectively, St. Jude") for infringement of Volcano's recently issued United States Patent Nos. 8,419,647 and 8,419,648 both entitled Ultra Miniature Pressure Sensor." Volcano's complaint accuses St. Jude's PressureWire Certus and PressureWire Aeris cardiac pressure sensing guide wire products (the Accused Guide Wires") and St. Jude's RadiAnalyzer Xpress Measurement System, Ilumien PCI Optimization System and Quantien Integrated FFR Platform, which are used with the Accused Guide Wires, of infringing the patented methods of United States Patent No. 8,419,647. Volcano's complaint also accuses the Accused Guide Wires of infringing the patented device claims of United States Patent No. 8,419,648.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVSC:US $0.00 USD 0.00

CVSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CVSC.
View Industry Companies

Industry Analysis


Industry Average

Valuation CVSC Industry Range
Price/Earnings 0.0x
Price/Sales 0.0x
Price/Book 0.0x
Price/Cash Flow 0.0x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOVASCULAR SCIENCES INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at